cacophony
发表于 2025-3-30 10:40:47
http://reply.papertrans.cn/83/8285/828446/828446_51.png
BUDGE
发表于 2025-3-30 15:07:17
http://reply.papertrans.cn/83/8285/828446/828446_52.png
反抗者
发表于 2025-3-30 16:41:56
http://reply.papertrans.cn/83/8285/828446/828446_53.png
敲诈
发表于 2025-3-31 00:21:58
http://reply.papertrans.cn/83/8285/828446/828446_54.png
沉默
发表于 2025-3-31 02:20:18
Overcoming Cancer Cell Resistance to Death Receptor Targeted Therapiesracterized by an intracellular death domain, which transmits a death signal from their cognate ligands, including TNF-related apoptosis inducing ligand (TRAIL). Currently, multiple clinical trials are underway to evaluate the antitumor activity of recombinant human TRAIL and agonistic antibodies to
阴谋
发表于 2025-3-31 08:33:15
http://reply.papertrans.cn/83/8285/828446/828446_56.png
占卜者
发表于 2025-3-31 11:36:43
Epithelial Mesenchymal Transition Influence on CTL Activity to promote invasion and metastasis. This review critically assesses whether EMT confers stemness, resistance to chemo- and targeted therapeutics, and immune escape. EMT inducers share common targets that alter apico-basal polarity, intercellular adhesion and the actin cytoskeleton, events that also